Faes Farma, S.A. (BME:FAE)

Market Cap	1.33B
Revenue (ttm)	524.02M
Net Income (ttm)	109.27M
Shares Out	311.25M
EPS (ttm)	0.35
PE Ratio	12.15
Forward PE	15.18
Dividend	0.16 (3.66%)
Ex-Dividend Date	Jan 9, 2025

Volume	312,246
Average Volume	362,310
Open	4.270
Previous Close	4.285
Day's Range	4.200 - 4.290
52-Week Range	3.270 - 4.370
Beta	0.29
RSI	64.27
Earnings Date	Apr 30, 2025

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 1,775
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: FAE

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.